US 12,070,735 B2
Chromatography medium
Oliver Hardick, London (GB); Daniel Gilbert Bracewell, London (GB); and Stewart Dods, London (GB)
Assigned to PURIDIFY LTD., Stevanage (GB)
Filed by Puridify Ltd., Stevanage (GB)
Filed on Oct. 23, 2020, as Appl. No. 17/078,435.
Application 17/078,435 is a continuation of application No. 15/091,158, filed on Apr. 5, 2016, granted, now 10,850,259.
Application 15/091,158 is a continuation in part of application No. PCT/GB2014/000401, filed on Oct. 9, 2014.
Application 15/091,158 is a continuation in part of application No. PCT/GB2013/052626, filed on Oct. 9, 2013.
Prior Publication US 2021/0162370 A1, Jun. 3, 2021
Int. Cl. B01D 39/14 (2006.01); B01D 15/32 (2006.01); B01D 15/36 (2006.01); B01D 15/38 (2006.01); B01D 39/16 (2006.01); B01J 20/24 (2006.01); B01J 20/26 (2006.01); B01J 20/28 (2006.01); B01J 20/285 (2006.01); B01J 20/287 (2006.01); B01J 20/288 (2006.01); B01J 20/30 (2006.01); B01J 39/05 (2017.01); B01J 39/19 (2017.01); B01J 39/26 (2006.01); B01J 41/07 (2017.01); B01J 41/13 (2017.01); B01J 41/20 (2006.01); B29C 65/00 (2006.01); B29C 65/02 (2006.01); B32B 5/02 (2006.01); B32B 27/08 (2006.01); B32B 27/12 (2006.01); B32B 27/32 (2006.01); B32B 37/06 (2006.01); B32B 37/10 (2006.01); B32B 37/18 (2006.01); C07K 1/16 (2006.01); C07K 1/18 (2006.01); C07K 1/20 (2006.01); C07K 1/22 (2006.01); B29K 601/00 (2006.01); B29K 627/18 (2006.01); B29L 9/00 (2006.01); C12M 1/12 (2006.01)
CPC B01J 20/265 (2013.01) [B01D 15/327 (2013.01); B01D 15/361 (2013.01); B01D 15/362 (2013.01); B01D 15/363 (2013.01); B01D 15/38 (2013.01); B01D 15/3804 (2013.01); B01D 15/3809 (2013.01); B01D 15/3819 (2013.01); B01D 39/14 (2013.01); B01D 39/16 (2013.01); B01D 39/1623 (2013.01); B01J 20/24 (2013.01); B01J 20/28007 (2013.01); B01J 20/28033 (2013.01); B01J 20/28038 (2013.01); B01J 20/28083 (2013.01); B01J 20/28085 (2013.01); B01J 20/285 (2013.01); B01J 20/287 (2013.01); B01J 20/288 (2013.01); B01J 20/3007 (2013.01); B01J 20/3085 (2013.01); B01J 39/05 (2017.01); B01J 39/19 (2017.01); B01J 39/26 (2013.01); B01J 41/07 (2017.01); B01J 41/13 (2017.01); B01J 41/20 (2013.01); B29C 65/02 (2013.01); B29C 66/45 (2013.01); B29C 66/712 (2013.01); B29C 66/7294 (2013.01); B32B 5/022 (2013.01); B32B 27/08 (2013.01); B32B 27/12 (2013.01); B32B 27/322 (2013.01); B32B 37/06 (2013.01); B32B 37/10 (2013.01); B32B 37/182 (2013.01); C07K 1/165 (2013.01); C07K 1/18 (2013.01); C07K 1/20 (2013.01); C07K 1/22 (2013.01); B01J 2220/54 (2013.01); B29K 2601/12 (2013.01); B29K 2627/18 (2013.01); B29K 2713/00 (2013.01); B29L 2009/00 (2013.01); B32B 2262/04 (2013.01); B32B 2317/18 (2013.01); B32B 2327/18 (2013.01); C07K 1/16 (2013.01); C12M 25/14 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A chromatography medium suitable for isolating biological molecules from mobile phases, wherein the chromatography medium comprises a stack of multiple non-woven sheets, wherein each non-woven sheet comprises polymer nanofibres and has a density of at least 200 kg/m3, wherein the stack of multiple non-woven sheets comprises fused points of contact between each adjacent sheet, and wherein said polymer nanofibres have mean diameters from 10 nm to 1000 nm.